Last updated: 21 July 2019 at 11:51pm EST

Matthew Pfeffer Net Worth




The estimated Net Worth of Matthew J Pfeffer is at least $771 mil dollars as of 30 June 2017. Mr. Pfeffer owns over 2,000 units of Vivani Medical Inc stock worth over $342,034 and over the last 16 years he sold EYES stock worth over $428,800. In addition, he makes $0 as Acting Chief Executive Officer e Director at Vivani Medical Inc.

Mr. Pfeffer EYES stock SEC Form 4 insiders trading

Matthew has made over 15 trades of the Vivani Medical Inc stock since 2009, according to the Form 4 filled with the SEC. Most recently he bought 2,000 units of EYES stock worth $2,460 on 30 June 2017.

The largest trade he's ever made was buying 25,000 units of Vivani Medical Inc stock on 15 August 2016 worth over $24,750. On average, Matthew trades about 2,798 units every 72 days since 2008. As of 30 June 2017 he still owns at least 82,617 units of Vivani Medical Inc stock.

You can see the complete history of Mr. Pfeffer stock trades at the bottom of the page.





Matthew Pfeffer biography

Matthew Jonathan Pfeffer CPA serves as Acting Chief Executive Officer, Director of the Company. Mr. Pfeffer served as a member of the board of directors of MannKind Corporation from January 2016 through October 2017, and served as a special adviser to the company from November 2017 through February 2019. He served as Chief Executive Officer and Chief Financial Officer of MannKind from January 2016 through May 2017, and as Corporate Vice President and Chief Financial Officer of MannKind from April 2008 until January 2016. Previously, Mr. Pfeffer served as Chief Financial Officer and Senior Vice President of Finance and Administration of VaxGen, Inc. from March 2006 until April 2008, with responsibility for finance, tax, treasury, human resources, information technology, purchasing and facilities functions. Prior to VaxGen, Mr. Pfeffer served as Chief Financial Officer of Cell Genesys, Inc. During his nine-year tenure at Cell Genesys, Mr. Pfeffer served as Director of Finance before being named Chief Financial Officer in 1998. Prior to that, Mr. Pfeffer served in a variety of financial management positions at other companies, including roles as Corporate Controller, Manager of Internal Audit and Manager of Financial Reporting. Mr. Pfeffer began his career at Price Waterhouse. Mr. Pfeffer graduated from the University of California, Berkeley and is a Certified Public Accountant.



How old is Matthew Pfeffer?

Matthew Pfeffer is 61, he's been the Acting Chief Executive Officer e Director of Vivani Medical Inc since 2020. There are 5 older and 6 younger executives at Vivani Medical Inc. The oldest executive at Vivani Medical Inc is Aaron Mendelsohn, 67, who is the Independent Director.

What's Matthew Pfeffer's mailing address?

Matthew's mailing address filed with the SEC is 28903 NORTH AVENUE PAINE, , VALENCIA, CA, 91355.

Insiders trading at Vivani Medical Inc

Over the last 10 years, insiders at Vivani Medical Inc have traded over $9,497,123 worth of Vivani Medical Inc stock and bought 22,269,890 units worth $31,710,900 . The most active insiders traders include Alfred E Mann, Gregg Williams, eE. Mann Living Trust Incume.... On average, Vivani Medical Inc executives and independent directors trade stock every 31 days with the average trade being worth of $1,432,564. The most recent stock trade was executed by Gregg Williams on 13 June 2022, trading 3,800 units of EYES stock currently worth $7,600.



What does Vivani Medical Inc do?

Second Sight Medical Products, Inc. (NASDAQ: EYES) develops, manufactures and markets implantable visual prosthetics that are intended to deliver useful artificial vision to blind individuals. A recognized global leader in neuromodulation devices for blindness, the Company is committed to developing new technologies to treat the broadest population of sight-impaired individuals. The Company's headquarters are in Los Angeles, California.



What does Vivani Medical Inc's logo look like?

Vivani Medical Inc logo

Complete history of Mr. Pfeffer stock trades at Mannkind Corp e Vivani Medical Inc

Data
#
Companhia
Acionista maioritário
Trans.
Transação
Ações Preço por ação Preço total Ações após Fonte
30 Jun 2017 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Comprar 2,000 $1.23 $2,460
30 Jun 2017
82,617
3 Jan 2017 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Comprar 4,540 $0.54 $2,452
3 Jan 2017
403,085
15 Aug 2016 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Comprar 25,000 $0.99 $24,750
15 Aug 2016
397,996
1 Jul 2014 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Venda 20,000 $10.44 $208,800
1 Jul 2014
126,784
30 Jun 2014 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Comprar 527 $4.42 $2,329
30 Jun 2014
146,784
4 Jun 2014 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Venda 10,000 $10.00 $100,000
4 Jun 2014
146,257
31 Dec 2013 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Comprar 487 $4.53 $2,206
31 Dec 2013
156,257
1 Aug 2013 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Exercício de opção 10,000 $2.86 $28,600
1 Aug 2013
93,654
2 Jul 2013 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Venda 10,000 $7.00 $70,000
2 Jul 2013
83,654
30 Jun 2013 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Comprar 7,448 $1.96 $14,598
30 Jun 2013
93,654
15 May 2013 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Venda 10,000 $5.00 $50,000
15 May 2013
86,206
31 Dec 2012 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Comprar 1,056 $1.95 $2,059
31 Dec 2012
96,206
30 Jun 2012 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Comprar 1,054 $1.95 $2,055
30 Jun 2012
78,150
18 Jan 2011 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Exercício de opção 6,300 $2.86 $18,018
18 Jan 2011
49,327
18 May 2009 Matthew J Pfeffer
Corporate VP e Diretor Financeiro
Exercício de opção 6,300 $1.44 $9,072
18 May 2009
35,157


Vivani Medical Inc executives and stock owners

Vivani Medical Inc executives and other stock owners filed with the SEC include: